Login to Your Account



Adolor Prepares For Entereg Bowel Dysfunction Phase III

By Karen Pihl-Carey


Wednesday, March 9, 2005
A few months after Entereg missed its endpoint in a Phase III European trial for post-operative ileus, the drug showed some promising benefits in a Phase II trial for opioid-induced bowel dysfunction, which Adolor Corp. reported Tuesday. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription